- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2016-000193-38.
Displaying page 1 of 1.
EudraCT Number: 2016-000193-38 | Sponsor Protocol Number: ENGOT-EN1/FANDANGO | Start Date*: 2016-06-20 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Nordic Society of Gynaecological Oncology (NSGO) - CTU | ||||||||||||||||||||||||||||||||||||||
Full Title: ENGOT-EN1/FANDANGO: A randomized phase II trial of first-line combination chemotherapy with nintedanib / placebo for patients with advanced or recurrent endometrial cancer. | ||||||||||||||||||||||||||||||||||||||
Medical condition: Histological confirmed endometrial cancer. (FIGO 2009) stage 3C2 or stage 4 or relapsed after adjuvant therapy for stage 1-3 disease. | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: SE (Completed) DK (Prematurely Ended) DE (Completed) FI (Completed) BE (Completed) FR (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
